Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83 GBX | +0.61% | -10.27% | -27.83% |
May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
May. 23 | Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer | CI |
Financials (USD)
Sales 2021 | - | Sales 2022 | 0.02 | Capitalization | 31.14M |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | -17M | EV / Sales 2021 * | - |
Net cash position 2021 | 4.46M | Net cash position 2022 | 429K | EV / Sales 2022 | 1,279,759,792 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-1.71
x | Employees | 27 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 34.5% |
1 day | -2.36% | ||
1 week | -15.21% | ||
Current month | -6.34% | ||
1 month | -20.64% | ||
3 months | -17.38% | ||
6 months | -21.41% | ||
Current year | -29.96% |
Managers | Title | Age | Since |
---|---|---|---|
James Short
FOU | Founder | 55 | 17-12-31 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
Iqbal Gill
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Firth
BRD | Director/Board Member | 62 | 18-09-16 |
Ian Anton
CHM | Chairman | 64 | 22-03-27 |
Robert Barr
BRD | Director/Board Member | 65 | 22-03-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 83 | +0.61% | 34 309 |
24-06-05 | 82.5 | -0.60% | 36,021 |
24-06-04 | 83 | -5.14% | 131,106 |
24-06-03 | 87.5 | +1.74% | 27,300 |
24-05-31 | 86 | -9.47% | 226,466 |
Delayed Quote London S.E., June 06, 2024 at 03:20 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-29.96% | 69.25M | |
+42.69% | 749B | |
+38.82% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.30% | 248B | |
-2.94% | 214B | |
+11.06% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- CEL Stock